PureTech Makes Senior Appointments
Executive Summary
PureTech Health PLC, has appointed Jeff Stevens vice president of growth strategy and operations and added Feng Zhang to its scientific advisory board (SAB). PureTech has also expanded its team of senior advisors to include Meghan Fitzgerald, executive vice president of corporate strategy, M&A and health policy at Cardinal Health; Atul Pande, former senior vice president and head of neurosciences at GlaxoSmithKline PLC and Philip J. Larsen, global head of diabetes research & development at Sanofi.
You may also be interested in...
Pipeline Watch: Five Approvals And 23 Phase III Updates
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Executives On The Move: Changes At The Top At Viatris And Clinuvel Among This Week's Announcements
Recent moves in the industry include C-suite shuffle at Brainstorm Cell Therapeutics and new CFOs at Faron Pharmaceuticals and Foghorn Therapeutics, among others.
Pipeline Watch: Six Approvals And 15 Phase III Updates
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.